1. P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE. (23rd June 2022) Authors: Bomben, R.; Rossi, F. M.; Vit, F.; Bittolo, T.; Zucchetto, A.; Papotti, R.; Tissino, E.; Pozzo, F.; Degan, M.; Zaina, E.; Cattarossi, I.; Nanni, P.; Marasca, R.; Reda, G.; Laurenti, L.; Olivieri, J.; Chiarenza, A.; Ballotta, L.; Cuneo, A.; Gentile, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Role of d16HER2 in HER2-positive breast cancer stem cells. (July 2016) Authors: Castagnoli, L.; Ghedini, G.C.; Koschorke, A.; Chiodoni, C.; Nanni, P.; Tagliabue, E.; Pupa, S.M. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗